These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7687066)

  • 1. Combined external beam and low dose rate intraluminal radiotherapy in oesophageal cancer.
    Caspers RJ; Zwinderman AH; Griffioen G; Welvaart K; Sewsingh EN; Davelaar J; Leer JW
    Radiother Oncol; 1993 Apr; 27(1):7-12. PubMed ID: 7687066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination external and internal radiotherapy for esophageal carcinoma: a new prospect].
    Caspers RJ; Zwinderman AH; Griffioen G; Welvaart K; Leer JW
    Ned Tijdschr Geneeskd; 1993 Feb; 137(9):465-8. PubMed ID: 7680440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
    Greene FL; Boulware RJ; Bianco J
    Surg Laparosc Endosc; 1995 Dec; 5(6):425-30. PubMed ID: 8611986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iridium-192 high dose rate brachytherapy combined with external beam irradiation in non-resectable oesophageal cancer.
    Pakisch B; Kohek P; Poier E; Stücklschweiger G; Poschauko J; Raith J; Quehenberger F; Mayer R; Hackl A
    Clin Oncol (R Coll Radiol); 1993; 5(3):154-8. PubMed ID: 7688549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined external and intraluminal radiotherapy in the treatment of advanced oesophageal cancer.
    Hujala K; Sipilä J; Minn H; Ruotsalainen P; Grenman R
    Radiother Oncol; 2002 Jul; 64(1):41-5. PubMed ID: 12208574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal brachytherapy: Institut Gustave Roussy's experience.
    Kissel M; Chirat E; Annede P; Burtin P; Fumagalli I; Bronsart E; Mignot F; Schernberg A; Dumas I; Haie-Meder C; Chargari C
    Brachytherapy; 2020; 19(4):499-509. PubMed ID: 32444283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of toxicity following external beam irradiation preceded by high-dose rate brachytherapy in inoperable oesophageal cancer.
    Taal BG; Aleman BM; Koning CC; Boot H
    Eur J Cancer; 1996 Sep; 32A(10):1815-8. PubMed ID: 8983296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group.
    Okawa T; Dokiya T; Nishio M; Hishikawa Y; Morita K
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):623-8. PubMed ID: 10524414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of irradiation treatment in patients with non-resectable oesophageal cancer.
    Kohek PH; Pakisch B; Glanzer H; Höss G; Mischinger HJ; Wolf G; Steindorfer P
    Eur J Surg Oncol; 1995 Dec; 21(6):627-31. PubMed ID: 8631409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraluminal high dose rate brachytherapy combined with external radiotherapy in the treatment of oesophageal cancer.
    Barone D; Coccia G; Marziano C; Tricerri R; Bonelli L; Tomassini E; Bistolfi F
    Panminerva Med; 1993 Jun; 35(2):86-92. PubMed ID: 8414629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined external beam and intracavitary radiotherapy in oesophageal carcinoma.
    Agrawal RK; Dawes PJ; Clague MB
    Clin Oncol (R Coll Radiol); 1992 Jul; 4(4):222-7. PubMed ID: 1377931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
    Chang LF; Horvath J; Peyton W; Ling SS
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer.
    Alden ME; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):945-51. PubMed ID: 8138448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of roentogenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low dose rate brachytherapy.
    Saito M; Yokoyama A; Kurita Y; Uematsu T; Miyao H; Fujimori K
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1029-35. PubMed ID: 8600085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
    Sur RK; Donde B; Levin VC; Mannell A
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: second report.
    Saito M; Yokoyama A; Kurita Y; Uematsu T; Tsukada H; Yamanoi T
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):673-80. PubMed ID: 10837951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer.
    Harms W; Krempien R; Grehn C; Berns C; Hensley FW; Debus J
    Br J Radiol; 2005 Mar; 78(927):236-41. PubMed ID: 15730988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.